Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-15

Clinical Trial Update: Role of NSI in Differentiating Between Mild Traumatic Brain Injury And Behavioral Health Conditions

View source ↗

Summary

A VA-sponsored clinical trial evaluating NSI to differentiate mild traumatic brain injury from behavioral health conditions has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VA Eastern Colorado Health Care System | Conditions: Traumatic Brain Injury, Post-Concussive Symptoms | Status: TERMINATED